Int'l Vaccine Institute to lead clinical trial in Nepal Sanofi and GSK received approval for their Phase 3 clinical study in Nepal to assess the safety, efficacy, and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine candidate. Nepal 01 Oct, 2021
Asia welcomes US vaccine donations amid cold storage worries Health officials and experts in Asia have welcomed U.S. plans to share 500 million more doses of the Pfizer vaccine with the developing world, but some say it would take more than donations alone to address huge vaccination gaps that threaten to prolong the pandemic. World 10 Jun, 2021
'At war time speed', China leads COVID-19 vaccine race SEOUL/SINGAPORE: China is forging ahead in the race to develop a vaccine to help control the COVID-19 pandemic, with Sinovac Biotech's experimental vaccine set to become the country's second and the world's third to enter final stage testing later...
